Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
Mayo Clinic
Mayo Clinic
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Roswell Park Cancer Institute
First Affiliated Hospital of Zhejiang University
National Institutes of Health Clinical Center (CC)
Stanford University
Memorial Sloan Kettering Cancer Center
Milton S. Hershey Medical Center
University of Chicago
Hackensack Meridian Health
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Ossium Health, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
Washington University School of Medicine
Tang-Du Hospital
Thomas Jefferson University
City of Hope Medical Center
Baylor Research Institute
University of Michigan Rogel Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center